ALTEOGEN Market Cap

ALTEOGEN has a market cap or net worth of 19.69 trillion as of June 6, 2025. Its market cap has increased by 109.62% in one year.

Market Cap

19.69T

Enterprise Value

19.50T

Revenue

151.65B

Ranking

n/a

PE Ratio

158.07

Stock Price

368,500.00

Market Cap Chart

Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 19.69T, an increase of 16,316.99%. That is a compound annual growth rate of 62.64%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	19.69T	19.39%
Dec 30, 2024	16.49T	221.05%
Dec 28, 2023	5,137.84B	160.78%
Dec 29, 2022	1,970.17B	-38.41%
Dec 30, 2021	3,198.72B	-36.62%
Dec 30, 2020	5,046.50B	442.81%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.59T
Celltrion	34.68T
Yuhan	7,718.75B
SK Biopharmaceuticals	7,024.70B
HLB Co., Ltd.	6,741.95B
PharmaResearch	4,987.03B
LigaChem Biosciences	4,045.74B
Hanmi Pharm.	3,791.38B

Market Cap Rankings